BioSmart Co.Ltd (038460) - Net Assets

Latest as of September 2025: ₩178.85 Billion KRW ≈ $121.20 Million USD

Based on the latest financial reports, BioSmart Co.Ltd (038460) has net assets worth ₩178.85 Billion KRW (≈ $121.20 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩287.99 Billion ≈ $195.17 Million USD) and total liabilities (₩109.14 Billion ≈ $73.96 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 038460 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩178.85 Billion
% of Total Assets	62.1%
Annual Growth Rate	13.98%
5-Year Change	33.79%
10-Year Change	120.14%
Growth Volatility	18.72

BioSmart Co.Ltd - Net Assets Trend (2010–2024)

This chart illustrates how BioSmart Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore BioSmart Co.Ltd asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for BioSmart Co.Ltd (2010–2024)

The table below shows the annual net assets of BioSmart Co.Ltd from 2010 to 2024. For live valuation and market cap data, see market cap of BioSmart Co.Ltd.

Year	Net Assets	Change
2024-12-31	₩129.48 Billion ≈ $87.75 Million	+6.46%
2023-12-31	₩121.63 Billion ≈ $82.43 Million	+25.75%
2022-12-31	₩96.72 Billion ≈ $65.55 Million	-2.39%
2021-12-31	₩99.10 Billion ≈ $67.16 Million	+2.40%
2020-12-31	₩96.78 Billion ≈ $65.59 Million	-8.24%
2019-12-31	₩105.47 Billion ≈ $71.47 Million	+31.03%
2018-12-31	₩80.49 Billion ≈ $54.55 Million	+24.29%
2017-12-31	₩64.76 Billion ≈ $43.89 Million	+9.41%
2016-12-31	₩59.19 Billion ≈ $40.11 Million	+0.64%
2015-12-31	₩58.82 Billion ≈ $39.86 Million	+16.57%
2014-12-31	₩50.46 Billion ≈ $34.19 Million	+8.41%
2013-12-31	₩46.54 Billion ≈ $31.54 Million	+21.42%
2012-12-31	₩38.33 Billion ≈ $25.98 Million	+8.80%
2011-12-31	₩35.23 Billion ≈ $23.88 Million	+69.89%
2010-12-31	₩20.74 Billion ≈ $14.05 Million	--

Equity Component Analysis

This analysis shows how different components contribute to BioSmart Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 6645.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	₩48.20 Billion	37.22%
Common Stock	₩13.08 Billion	10.10%
Other Components	₩68.20 Billion	52.67%
Total Equity	₩129.48 Billion	100.00%

BioSmart Co.Ltd Competitors by Market Cap

The table below lists competitors of BioSmart Co.Ltd ranked by their market capitalization.

Company	Market Cap
Introl S.A. WAR:INL	$54.05 Million
GP Global Power Ltd TA:GPGB	$54.05 Million
Taiwan Taffeta Fabric Co Ltd TW:1454	$54.06 Million
Voksel Electric Tbk JK:VOKS	$54.06 Million
Sambu Const KO:001470	$54.01 Million
Unique Optical Industrial Co Ltd TWO:3441	$53.99 Million
Latitude Tree Holdings Bhd KLSE:7006	$53.99 Million
KWG Group Holdings Limited F:KOU	$53.96 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in BioSmart Co.Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 111,691,289,860 to 129,484,272,150, a change of 17,792,982,290 (15.9%).
Net income of 127,171,570 contributed positively to equity growth.
Share repurchases of 7,995,831,150 reduced equity.
New share issuances of 8,185,331,150 increased equity.
Other factors increased equity by 17,476,310,720.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	₩127.17 Million	+0.1%
Share Repurchases	₩8.00 Billion	-6.18%
Share Issuances	₩8.19 Billion	+6.32%
Other Changes	₩17.48 Billion	+13.5%
Total Change	₩-	15.93%

Book Value vs Market Value Analysis

This analysis compares BioSmart Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.78x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.17x to 0.78x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩3396.15	₩3990.00	x
2017-12-31	₩3659.99	₩3990.00	x
2018-12-31	₩4029.04	₩3990.00	x
2019-12-31	₩5269.81	₩3990.00	x
2020-12-31	₩5041.12	₩3990.00	x
2021-12-31	₩5161.94	₩3990.00	x
2022-12-31	₩5038.31	₩3990.00	x
2023-12-31	₩5604.99	₩3990.00	x
2024-12-31	₩5123.11	₩3990.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently BioSmart Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.10%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.03%
• Asset Turnover: 1.84x
• Equity Multiplier: 2.03x
Recent ROE (0.10%) is below the historical average (4.92%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	0.97%	1.00%	0.49x	1.99x	₩-3.13 Billion
2012	7.49%	6.74%	0.61x	1.81x	₩-955.35 Million
2013	8.47%	9.81%	0.56x	1.54x	₩-716.20 Million
2014	1.45%	1.79%	0.61x	1.33x	₩-4.37 Billion
2015	5.35%	5.81%	0.73x	1.27x	₩-2.73 Billion
2016	1.05%	0.98%	0.56x	1.89x	₩-5.30 Billion
2017	7.45%	6.00%	0.71x	1.74x	₩-1.65 Billion
2018	6.38%	4.36%	0.83x	1.76x	₩-2.91 Billion
2019	21.00%	13.93%	0.87x	1.74x	₩11.60 Billion
2020	-9.03%	-5.25%	0.99x	1.74x	₩-18.41 Billion
2021	1.41%	0.74%	0.84x	2.28x	₩-8.52 Billion
2022	0.75%	0.18%	1.65x	2.45x	₩-8.95 Billion
2023	16.03%	3.93%	1.75x	2.33x	₩6.74 Billion
2024	0.10%	0.03%	1.84x	2.03x	₩-12.82 Billion

Industry Comparison

This section compares BioSmart Co.Ltd's net assets metrics with peer companies in the Electronic Equipment & Parts industry.

Industry Context

Industry: Electronic Equipment & Parts
Average net assets among peers: $104,328,301,207
Average return on equity (ROE) among peers: -0.31%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
BioSmart Co.Ltd (038460)	₩178.85 Billion	0.97%	0.61x	$54.02 Million
SANGBO Corp (027580)	$56.78 Billion	3.49%	1.35x	$12.75 Million
Inzi Display Co.Ltd (037330)	$145.68 Billion	3.75%	0.82x	$35.17 Million
e-LITECOM CO. Ltd (041520)	$233.34 Billion	16.70%	0.47x	$99.11 Million
CoAsia Corporation (045970)	$108.86 Billion	18.21%	1.53x	$74.57 Million
Powerlogics Co. Ltd (047310)	$89.77 Billion	0.00%	1.49x	$122.23 Million
Phoenix Materials Co. Ltd (050090)	$43.28 Billion	-4.01%	1.34x	$35.59 Million
CammSys Corp (050110)	$73.34 Billion	0.00%	1.16x	$70.66 Million
STCube Inc (052020)	$38.70 Billion	-27.66%	0.51x	$345.77 Million
Amotech Co. Ltd (052710)	$149.20 Billion	-13.26%	1.38x	$129.86 Million

About BioSmart Co.Ltd

KQ:038460 Korea Electronic Equipment & Parts

Market Cap

$54.02 Million

₩79.71 Billion KRW

Market Cap Rank

#21640 Global

#1404 in Korea

Share Price

₩3990.00

Change (1 day)

-2.33%

52-Week Range

₩2670.00 - ₩6250.00

All Time High

₩14975.32